Terms: = Lymphoma AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9
1646 results:
1. Novel therapeutic strategies for rare mutations in non-small cell lung cancer.
Gou Q; Gou Q; Gan X; Xie Y
Sci Rep; 2024 May; 14(1):10317. PubMed ID: 38705930
[TBL] [Abstract] [Full Text] [Related]
2. Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report.
Nagamatsu Y; Isoda T; Inaji M; Oyama J; Niizato D; Tomomasa D; Mitsuiki N; Yamashita M; Kamiya T; Imai K; Kanegane H; Morio T; Takagi M
BMC Pediatr; 2024 May; 24(1):304. PubMed ID: 38704558
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of Native Myocardial T1 Mapping for Early Detection of Anthracycline-Induced Cardiotoxicity in Patients with Cancer: a Systematic Review and meta-analysis.
Mohamed AA; Elmancy LY; Abulola SM; Al-Qattan SA; Mohamed Ibrahim MI; Maayah ZH
Cardiovasc Toxicol; 2024 Jun; 24(6):563-575. PubMed ID: 38700665
[TBL] [Abstract] [Full Text] [Related]
4. Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma.
Gatwood J; Masaquel A; Fox D; Sheinson D; James C; Li J; Hossain F; Ross R
J Med Econ; 2024; 27(1):738-745. PubMed ID: 38686393
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin lymphoma.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Iyer S; Ferrajoli A; Danilov AV; Giordano SH
JCO Clin Cancer Inform; 2024 Apr; 8():e2300223. PubMed ID: 38684043
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel.
Ghilardi G; Paruzzo L; Patel V; Svoboda J; Chong ER; Fardella E; Chong EA; Gabrielli G; Nasta SD; Landsburg DJ; Carter J; Pajarillo R; Barta SK; White G; Weber E; Napier E; Porter DL; Garfall AL; Schuster SJ; Ruella M
J Hematol Oncol; 2024 Apr; 17(1):19. PubMed ID: 38644469
[TBL] [Abstract] [Full Text] [Related]
7. Evidence-Based Recommendations for Education Provided to Patients and Families Regarding the Adverse Events of ALK and MEK Inhibitors: A Systematic Review From the Children's Oncology Group.
Fisher B; Meyer A; Brown A; Conway Keller M; McKeown T; Tiller J; Saylor KM; Duffy EA
J Pediatr Hematol Oncol Nurs; 2024; 41(2):114-128. PubMed ID: 38549368
[No Abstract] [Full Text] [Related]
8. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Fertility and Forecasting Collaborators
Lancet; 2024 May; 403(10440):2057-2099. PubMed ID: 38521087
[TBL] [Abstract] [Full Text] [Related]
9. Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE.
Cartwright E; Slater S; Saffery C; Tran A; Turkes F; Smith G; Aresu M; Kohoutova D; Terlizzo M; Zhitkov O; Rana I; Johnston EW; Sanna I; Smyth E; Mansoor W; Fribbens C; Rao S; Chau I; Starling N; Cunningham D
ESMO Open; 2024 Apr; 9(4):102971. PubMed ID: 38518549
[TBL] [Abstract] [Full Text] [Related]
10. Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and met exon 14 skipping in NSCLC.
Melchior L; Hirschmann A; Hofman P; Bontoux C; Concha A; Mrabet-Dahbi S; Vannuffel P; Watkin E; Putzová M; Scarpino S; Cayre A; Martin P; Stoehr R; Hartmann A
Virchows Arch; 2024 Apr; 484(4):677-686. PubMed ID: 38492039
[TBL] [Abstract] [Full Text] [Related]
11. From Case Reports to Molecular Insight: Examining the Outcomes and Underlying Mechanisms of Squamous Cell Carcinoma in Breast Implant Patients-A Systematic Review.
Camicia A; Foppiani JA; Raska O; Hernandez Alvarez A; Lee D; Taritsa IC; Schuster KA; Wan R; Neradová S; Lin GJ; Lee TC; Molitor M; Zikan M; Lin SJ
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474119
[TBL] [Abstract] [Full Text] [Related]
12. Febrile Ulceronecrotic Mucha-Habermann Disease Associated With Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature.
Chen C; Fahmy LM; Schreidah CM; Magro CM; Geskin LJ
Am J Dermatopathol; 2024 Apr; 46(4):238-242. PubMed ID: 38457671
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of genomic alterations in Epstein-Barr virus-positive and Epstein-Barr virus-negative diffuse large B-cell lymphoma.
Liu F; Tian S; Liu Q; Deng Y; He Q; Shi Q; Chen G; Xu X; Yuan J; Nakamura S; Karube K; Wang Z
Cancer Med; 2024 Feb; 13(4):e6995. PubMed ID: 38457199
[TBL] [Abstract] [Full Text] [Related]
14. The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for lymphoma.
Andersen L; Baker KM; Difilippo H; Meghani SH; Porter D; Deng J
Semin Oncol Nurs; 2024 Apr; 40(2):151614. PubMed ID: 38443220
[TBL] [Abstract] [Full Text] [Related]
15. MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis.
Wang X; Shi Y; Shi H; Liu X; Liao A; Liu Z; Orlowski RZ; Zhang R; Wang H
J Exp Clin Cancer Res; 2024 Mar; 43(1):68. PubMed ID: 38439082
[TBL] [Abstract] [Full Text] [Related]
16. PD-L1 expression and its correlation with clinicopathological and molecular characteristics in Chinese patients with non-small cell lung cancer.
Guo J; Yuan H; Zhu Y; Che Z; Zhang B; Zhang D; Zhou Y; Xiong L
Medicine (Baltimore); 2024 Feb; 103(8):e36770. PubMed ID: 38394518
[TBL] [Abstract] [Full Text] [Related]
17. Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the lymphoma and Related Diseases Registry.
Baggio D; Wellard C; Chung E; Talaulikar D; Keane C; Opat S; Giri P; Minson A; Cheah CY; Armytage T; Lee D; Chong G; Johnston A; Cochrane T; Waters N; Hamad N; Wood EM; Hawkes EA
Leuk Lymphoma; 2023 Mar; 64(3):621-627. PubMed ID: 38376128
[TBL] [Abstract] [Full Text] [Related]
18. LncRNA CHROMR/miR-27b-3p/met axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma.
Liu C; Zhao X; Wang Z; Zhang C; Zheng W; Zhu X; Zhang D; Gong T; Zhao H; Li F; Guan T; Guo X; Zhang H; Yu B
J Biol Chem; 2024 Mar; 300(3):105762. PubMed ID: 38367665
[TBL] [Abstract] [Full Text] [Related]
19. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
[TBL] [Abstract] [Full Text] [Related]
20. Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and lymphoma during maintenance therapy.
Barone T; Dandekar S; McKeone D; Mulieri K
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1987. PubMed ID: 38351548
[TBL] [Abstract] [Full Text] [Related]
[Next]